Jessica Seeliger, Ph.D.

Research Project:
Targeting Latent and Multi-Drug Resistant TB

Grant Awarded:

Biomedical Research Grant

Research Topic:

basic biologic mechanisms

Research Disease:

tuberculosis

Mycobacterium tuberculosis (Mtb), infects one-third of the world's population. Most infected individuals have latent TB infections and have no symptoms. However, decreased immune responses can trigger latent TB to reactivate and cause infectious disease. Some TB disease can become resistant to first line medications and therefore, new therapies are needed to treat multi- and extremely drug-resistant TB strains. Dr. Seeliger and team will use a novel chemical method to evaluate a family of Mtb enzymes with diverse functions essential for bacterial survival as potential drug targets. These enzymes may be promising for developing next-generation therapies against latent infections and multi-drug resistant TB

Page last updated: March 8, 2022

Join the Patient & Caregiver Network

End Youth Vaping

10 Tips to Protect Yourself from Unhealthy Air

State of the Air Key Findings

Become an Advocate

Events Near You

Jessica Seeliger, Ph.D.

A Breath of Fresh Air in Your Inbox

Thank You!

Make a Donation

Become a Lung Health Insider

Select Your Location

Change Language

Lung HelpLine

1-800-LUNG-USA